Medical Equipment

Immunoassay Sector Forecast Shows Robust Momentum, Climbing to $52.83 Billion With 7.2% CAGR

February 5, 2026February 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Immunoassay Market covering 2026–2035?

The immunoassay market size has experienced robust growth in recent years. Looking ahead, this market is projected to expand from $37.32 billion in 2025 to $40.07 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. Historically, this expansion has been driven by factors such as the increasing prevalence of infectious and chronic diseases, a surge in clinical laboratory testing volumes, the broad use of ELISA-based diagnostics, intensified pharmaceutical research endeavors, and a heightened need for early disease detection.

The immunoassay market is expected to show significant growth in the upcoming years, with its size projected to reach $52.83 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This projected growth is attributed to factors such as the increasing demand for rapid diagnostics, rising investments in personalized medicine, the expansion of decentralized testing models, the growing adoption of digital laboratory workflows, and an increasing focus on companion diagnostics. Major trends anticipated during this period include the wider adoption of high-sensitivity immunoassay kits, increased utilization of automated immunoassay analyzers, a growing demand for point-of-care immunoassay testing, the expansion of multiplex immunoassay platforms, and enhanced integration of data management software.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Immunoassay Market?

The anticipated growth of the immunoassay market is set to be propelled by the rising prevalence of infectious and chronic illnesses. These conditions are defined as diseases caused by pathogens or long-term medical ailments requiring continuous monitoring, diagnosis, and management. An increase in exposure to environmental pollutants, which weaken immunity and heighten susceptibility to disease, is contributing to the rise of infectious and chronic illnesses. As a result, the immunoassay market is experiencing elevated demand, with the rapid expansion of these illnesses prompting companies to adopt advanced diagnostic tools that facilitate early detection, disease surveillance, and accurate clinical decision-making. For instance, in June 2025, the UK Health Security Agency (UKHSA), a United Kingdom-based government public health agency, reported that the number of Campylobacter cases in England climbed from 60,055 in 2023 to 70,352 cases in 2024. This signifies an increase of 10,297 cases (17.1%) and an uptick in the reporting rate from 104.1 to 121.9 per 100,000 population. Consequently, the increasing numbers of infectious and chronic illnesses are a key driver for the immunoassay market.

What Leading Segments Are Studied In The Immunoassay Market?

The immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

Which Market Trends Are Opening Growth Opportunities In The Immunoassay Market?

Leading companies active in the immunoassay market are introducing innovative immunoassay analyzers to secure a competitive edge. Immunoassay analyzers are sophisticated laboratory instruments designed to automate and streamline the detection and quantification of biological molecules, such as proteins or hormones, by leveraging immunological reactions. A significant development occurred in May 2023, when Beckman Coulter Diagnostics, a US-based company focused on simplifying, automating, and innovating complex biomedical testing, unveiled the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer addresses the needs of clinical laboratories for enhanced speed, reliability, reproducibility, quality, and menu expansion. It has shown the capacity to develop increasingly sensitive and clinically relevant assays, thus amplifying the effect of new pharmaceutical therapies and ultimately improving patient outcomes. This system features advancements like new analyte processing and detection technology, precision sensors, smart algorithms, and remote real-time system monitoring, notably being the sole immunoassay analyzer system that requires no daily maintenance.

Which Major Industry Participants Are Leading The Immunoassay Market Growth?

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Immunoassay Market?

North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Immunoassay Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Browse Through More Reports Similar to the Global Immunoassay Market 2026, By The Business Research Company

Immunohematology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunomodulator Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Immune Health Supplements Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795